[Epigenetic changes in malignant cells].
作者信息
Hackanson B, Lübbert M
机构信息
Medizinische Universitätsklinik Freiburg, Abteilung Hämatologie und Onkologie, Freiburg.
出版信息
Dtsch Med Wochenschr. 2011 Mar;136(10):475-9. doi: 10.1055/s-0031-1274530. Epub 2011 Mar 1.
PMID:21365524
Abstract
摘要
相似文献
1
[Epigenetic changes in malignant cells].
Dtsch Med Wochenschr. 2011 Mar;136(10):475-9. doi: 10.1055/s-0031-1274530. Epub 2011 Mar 1.
2
Multiple safeguards against tumour development.
J Intern Med. 2007 Nov;262(5):505-8. doi: 10.1111/j.1365-2796.2007.01859.x. Epub 2007 Oct 1.
3
Epigenetics: surveillance team against cancer.
Nature. 2005 Mar 10;434(7030):150. doi: 10.1038/434150a.
4
Setting and resetting of epigenetic marks in malignant transformation and development.
Bioessays. 2010 Aug;32(8):669-79. doi: 10.1002/bies.201000016.
5
[Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
Med Sci (Paris). 2008 Aug-Sep;24(8-9):725-30. doi: 10.1051/medsci/20082489725.
6
[Epigenetic changes and cancer].
Ann Pathol. 2009 Nov;29 Spec No 1:S17-8. doi: 10.1016/j.annpat.2009.07.020. Epub 2009 Oct 12.
7
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
8
Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.
Cancer Res. 2007 Jun 15;67(12):5583-6. doi: 10.1158/0008-5472.CAN-07-0846.
9
Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
J BUON. 2007 Sep;12 Suppl 1:S9-12.
10
Cancer: an epigenetic landscape.
Subcell Biochem. 2013;61:399-417. doi: 10.1007/978-94-007-4525-4_17.
引用本文的文献
1
The AML1/ETO target gene LAT2 interferes with differentiation of normal hematopoietic precursor cells.
Leuk Res. 2014 Mar;38(3):340-5. doi: 10.1016/j.leukres.2013.12.014. Epub 2013 Dec 25.
Zotero 插件